Европейски съюз -
български -
EMA (European Medicines Agency)
zydelig
gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.
Европейски съюз -
български -
EMA (European Medicines Agency)
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - Антинеопластични средства - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
България -
български -
БАБХ (Българска агенция по безопасност на храните)
clindavet - bg tabs 150 mg
provet s. a. - На базата на клиндамицин (под формата на хидрохлорид) - таблетки - 150 mg/таблетка - кучета
България -
български -
БАБХ (Българска агенция по безопасност на храните)
clindavet - bg tabs 75 mg
provet s. a. - На базата на клиндамицин (под формата на хидрохлорид) - таблетки - 75 mg/таблетка - кучета